These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24117255)

  • 1. The potential contribution of circulating and locally produced leptin to cardiac hypertrophy and failure.
    Karmazyn M; Gan XT; Rajapurohitam V
    Can J Physiol Pharmacol; 2013 Nov; 91(11):883-8. PubMed ID: 24117255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and Cellular Mechanisms Underlying the Cardiac Hypertrophic and Pro-Remodelling Effects of Leptin.
    Karmazyn M; Gan XT
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin as a cardiac hypertrophic factor: a potential target for therapeutics.
    Karmazyn M; Purdham DM; Rajapurohitam V; Zeidan A
    Trends Cardiovasc Med; 2007 Aug; 17(6):206-11. PubMed ID: 17662916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart.
    Karmazyn M; Purdham DM; Rajapurohitam V; Zeidan A
    Cardiovasc Res; 2008 Jul; 79(2):279-86. PubMed ID: 18474523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginseng (Panax quinquefolius) attenuates leptin-induced cardiac hypertrophy through inhibition of p115Rho guanine nucleotide exchange factor-RhoA/Rho-associated, coiled-coil containing protein kinase-dependent mitogen-activated protein kinase pathway activation.
    Moey M; Rajapurohitam V; Zeidan A; Karmazyn M
    J Pharmacol Exp Ther; 2011 Dec; 339(3):746-56. PubMed ID: 21875949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury.
    McGaffin KR; Sun CK; Rager JJ; Romano LC; Zou B; Mathier MA; O'Doherty RM; McTiernan CF; O'Donnell CP
    Cardiovasc Res; 2008 Jan; 77(1):54-63. PubMed ID: 18006469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin as a cardiac pro-hypertrophic factor and its potential role in the development of heart failure.
    Karmazyn M; Rajapurohitam V
    Curr Pharm Des; 2014; 20(4):646-51. PubMed ID: 23688017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of fat mass and obesity associated (FTO) protein expression in cardiomyocytes: regulation by leptin and its contribution to leptin-induced hypertrophy.
    Gan XT; Zhao G; Huang CX; Rowe AC; Purdham DM; Karmazyn M
    PLoS One; 2013; 8(9):e74235. PubMed ID: 24019958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation.
    Rajapurohitam V; Izaddoustdar F; Martinez-Abundis E; Karmazyn M
    Cell Signal; 2012 Dec; 24(12):2283-90. PubMed ID: 22917533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
    Rajapurohitam V; Javadov S; Purdham DM; Kirshenbaum LA; Karmazyn M
    J Mol Cell Cardiol; 2006 Aug; 41(2):265-74. PubMed ID: 16806260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose tissue as an endocrine organ.
    Ahima RS
    Obesity (Silver Spring); 2006 Aug; 14 Suppl 5():242S-249S. PubMed ID: 17021375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fitness or fatness--the debate continues for the role of leptin in obesity-associated heart dysfunction.
    Dong F; Ren J
    Curr Diabetes Rev; 2007 Aug; 3(3):159-64. PubMed ID: 18220667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenomenon of leptin resistance in seasonal animals: the failure of leptin action in the brain.
    Szczesna M; Zieba DA
    Domest Anim Endocrinol; 2015 Jul; 52():60-70. PubMed ID: 25863197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity.
    Wang MY; Orci L; Ravazzola M; Unger RH
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18011-6. PubMed ID: 16326804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin and its metabolic interactions: an update.
    Anubhuti ; Arora S
    Diabetes Obes Metab; 2008 Nov; 10(11):973-93. PubMed ID: 18284436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of leptin and adiponectin in breast cancer.
    Jardé T; Perrier S; Vasson MP; Caldefie-Chézet F
    Eur J Cancer; 2011 Jan; 47(1):33-43. PubMed ID: 20889333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Role of Leptin and Adiponectin in Cardiovascular System.
    Ghantous CM; Azrak Z; Hanache S; Abou-Kheir W; Zeidan A
    Int J Endocrinol; 2015; 2015():534320. PubMed ID: 26064110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin and cardiovascular diseases.
    Hou N; Luo JD
    Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):905-13. PubMed ID: 21957899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart spotting.
    el Azzouzi H; De Windt LJ
    Basic Res Cardiol; 2008 May; 103(3):228-31. PubMed ID: 18274799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.